SCHEMBL6359802

SCHEMBL6359802

Nc1cc(C(=O)OCc2ccccc2)ccc1B(O)O

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.55
TDP1 Q9NUW8 3/20 0.55
SLC6A2 P23975 1/20 0.55
SLC6A3 Q01959 1/20 0.55
LMNA P02545 3/20 0.55
MAPT P10636 5/20 0.52
ALDH1A1 P00352 4/20 0.52
HPGD P15428 2/20 0.52
RAB9A P51151 5/20 0.52
NPC1 O15118 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
GAA P10253 1/20 0.48
PRMT1 Q99873 1/20 0.47
JMJD6 Q6NYC1 1/20 0.47
SRD5A1 P18405 1/20 0.47
SRD5A2 P31213 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
KDM4E B2RXH2 1/20 0.45
PRKCZ Q05513 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4516565 0.84 KMT2A (0.64) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL10323667 0.83 TDP1 (0.58) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL8059715 0.81 LMNA (0.64) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL30306818 0.81 LMNA (0.64) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL8128313 0.81 TDP1 (0.60) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL6818034 0.81 ALDH1A1 (0.56) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL7423041 0.80 KMT2A (0.58) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL8138317 0.80 KMT2A (0.65) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL7557781 0.80 TDP1 (0.58) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL15754802 0.80 KMT2A (0.58) KMT2ATDP1SLC6A2SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050118209-A1 Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides BASF AKTIENGESELLSCHAFT (DE) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050118209-A1 Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides CAT, LPO, GPX4 KMT2A 2682/4885TDP1 1238/4885SLC6A2 3591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.